Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSP
751
Franklin Street Properties
FSP
$46.4M
| $29.3M | 0.02% |
3,460,200
+243,400
| +8% | +$1.91M |
|
752
PetMed Express
PETS
$43.4M
| $29.2M | 0.02% |
1,622,200
-292,715
| -15% | -$4.83M |
|
753
Manhattan Associates
MANH
$11.7B
| $29.2M | 0.02% |
361,960
+140,700
| +64% | +$11.3M |
|
754
Boeing
BA
$182B
| $29.2M | 0.02% |
76,700
+27,100
| +55% | +$9.69M |
|
|
MOBL
755
DELISTED
MobileIron, Inc.
MOBL
| $29.2M | 0.02% |
4,455,140
+1,012,200
| +29% | +$6.9M |
|
756
Universal Display
OLED
$4.18B
| $29.1M | 0.02% |
+173,601
| New | +$34.7M |
|
|
UCB
757
United Community Banks
UCB
$4.43B
| $29.1M | 0.02% |
1,025,968
-91,900
| -8% | -$2.52M |
|
|
IPHS
758
DELISTED
Innophos Holdings, Inc.
IPHS
| $29.1M | 0.02% |
895,600
+27,900
| +3% | +$804K |
|
|
JHG
759
DELISTED
Janus Henderson
JHG
| $29M | 0.02% |
1,291,100
-885,600
| -41% | -$18.4M |
|
|
BMTC
760
DELISTED
Bryn Mawr Bank Corp
BMTC
| $28.9M | 0.02% |
792,520
+19,800
| +3% | +$712K |
|
761
Watts Water Technologies
WTS
$12.8B
| $28.9M | 0.02% |
308,100
+75,700
| +33% | +$7.03M |
|
762
CF Industries
CF
$17.7B
| $28.8M | 0.02% |
+586,350
| New | +$28.4M |
|
763
James River Group Holdings
JRVR
$200M
| $28.7M | 0.02% |
560,400
+5,200
| +0.9% | +$254K |
|
|
PRMW
764
DELISTED
Primo Water Corporation
PRMW
| $28.7M | 0.02% |
2,301,002
-158,698
| -6% | -$2.02M |
|
765
Conduent
CNDT
$252M
| $28.7M | 0.02% |
4,610,500
+1,303,228
| +39% | +$10.1M |
|
766
CACI
CACI
$14.8B
| $28.7M | 0.02% |
124,000
+69,600
| +128% | +$15M |
|
767
First Merchants
FRME
$2.72B
| $28.6M | 0.02% |
759,866
+105,637
| +16% | +$3.95M |
|
768
Northwest Bancshares
NWBI
$2.31B
| $28.5M | 0.02% |
1,741,575
-364,271
| -17% | -$6.08M |
|
|
RST
769
DELISTED
ROSETTA STONE INC
RST
| $28.5M | 0.02% |
1,639,300
-143,000
| -8% | -$2.88M |
|
|
QADA
770
DELISTED
QAD Inc.
QADA
| $28.5M | 0.02% |
617,377
+6,100
| +1% | +$254K |
|
771
American Public Education
APEI
$828M
| $28.5M | 0.02% |
1,273,693
+4,100
| +0.3% | +$113K |
|
|
COUP
772
DELISTED
Coupa Software Incorporated
COUP
| $28.5M | 0.02% |
219,604
-3,696
| -2% | -$512K |
|
773
Carvana
CVNA
$81B
| $28.4M | 0.02% |
+2,151,000
| New | +$30.9M |
|
774
Berkshire Hathaway Class A
BRK.A
$1.09T
| $28.4M | 0.02% |
91
-55
| -38% | -$17M |
|
775
Haverty Furniture Companies
HVT
$450M
| $28.3M | 0.02% |
1,397,500
-39,900
| -3% | -$753K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.